Last Updated: November 13, 2026

Litigation Details for Fresenius Kabi USA, LLC v. Custopharm, Inc. (W.D. Tex. 2018)

« Back to Dashboard

Fresenius Kabi USA, LLC v. Custopharm, Inc. (W.D. Tex. 2018)

Docket	1:18-cv-00665	Date Filed	2018-08-06
Court	District Court, W.D. Texas	Date Terminated	2019-08-13
Cause	35:271 Patent Infringement	Assigned To	Earl Leroy Yeakel III
Jury Demand	Plaintiff	Referred To
Patents	7,828,787; 8,118,802; 8,162,915
Link to Docket	External link to docket

Small Molecule Drugs cited in Fresenius Kabi USA, LLC v. Custopharm, Inc.

The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .

Details for Fresenius Kabi USA, LLC v. Custopharm, Inc. (W.D. Tex. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2018-08-06				External link to document
2018-08-06	37	Amended Complaint	States Patent Nos. 8,118,802 (“the ‘802 patent”), 8,162,915 (“the ‘915 patent”), and 7,828,787 (“the … COUNT III FOR INFRINGEMENT OF U.S. PATENT NO. 7,828,787 66. The allegations of paragraphs… ‘787 patent”) (collectively, “the Patents-in-Suit”). This action arises out of Defendant’s filing of… BACKGROUND The Patents-in-Suit 24. The ‘802 patent, entitled “Connector for packaging…inventors assigned the ‘802 patent to Fresenius Kabi Deutschland GmbH. The ‘802 patent is listed in the Orange	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.